Skip to main content

Specialty Menu Navigation

  • COVID-19

  • Clinical

  • Coronary

  • Structural

  • Endovascular

  • Heart Failure

  • Heart Rhythm

  • Imaging & Physiology

  • Policy & Practice

Top User Menu

  • CME
  • Register
  • Login
Advertisement

Main navigation

  • News
    • Conference News
    • Features
    • Opinion
  • Conferences
  • Slides
  • Specialties
    • COVID-19
    • Clinical
    • Coronary
    • Structural
    • Endovascular
    • Heart Failure
    • Heart Rhythm
    • Imaging & Physiology
    • Policy & Practice
  • Podcasts
    • Heart Sounds
    • Rox Heart Radio
    • TCTMD Talking Points
    • Taking It To Heart
    • Heart Valve Matters
    • Hearts & Minds
  • Videos
    • All Videos
    • Interviews
    • Topical Discussions
    • On Record
    • Live Cases
    • Partner Content
  • Fellows Forum
  • CV Team Forum
  • AI Exchange
  • Slides (658)
  • News (209)
  • Videos (1)
  • Interview
Podcast
  • Conference News
  • Editor's Corner
  • Off Script
  • Industry News
  • Features
  • (-) TCT (868)
  • Coronary (453)
  • DES/BRS/DCB (181)
  • ACS/AMI (47)
  • Imaging & Physiology (37)
  • Cath Lab (35)
  • Endovascular (32)
  • Policy & Practice (30)
  • Clinical Cardiology (28)
  • CAD Pharma (26)
  • Structural Heart (21)
  • Angiography/QCA (16)
  • Cardiac Surgery (11)
  • OCT (10)
  • IVUS/NIRS (9)
  • CTO (8)
  • Heart Failure (8)
  • Femoral (7)
  • Aortic Valve (6)
  • Diabetes (6)
  • FFR (6)
  • Heart Rhythm (6)
  • Popliteal/Infrapopliteal (6)
  • Iliac (5)
  • Plaque Modification (5)
  • Carotid (3)
  • Mitral Valve (3)
  • Renovascular (3)
  • Vascular Access/Closure (3)
  • Aortic (2)
  • Hemodynamic Support (2)
  • Public Health (2)
  • Training (2)
  • Women's Heart (2)
  • Clinical Pharma (1)
  • Congenital (1)
  • Guidelines (1)
  • Hemodynamics (1)
  • Hypertension (1)
  • Hypertrophic Cardiomyopathy (1)
  • Left Atrial Appendage (1)
  • PFO/ASD (1)
  • Prevention (1)
  • Quality (1)
  • Tricuspid Valve (1)
  • 2025 (22)
  • 2024 (35)
  • 2023 (25)
  • 2022 (11)
  • 2021 (19)
  • 2020 (19)
  • 2019 (40)
  • 2018 (92)
  • 2017 (94)
  • 2016 (506)
Displaying 801 - 820 of 868
Sort: Relevancy | Date
Twelve-Month Clinical Efficacy and Safety of Zotarolimus- versus Everolimus-Eluting Stents in a Series of Asian Population
Presentation TCT 2012

Twelve-Month Clinical Efficacy and Safety of Zotarolimus- versus Everolimus-Eluting Stents in a Series of Asian Population

Presenter: SunWon Kim, Seung Woon Rha, Byoung Geol Choi, Amro Elnagar, Sung Il Im, Jin Oh Na, Seong Woo Han, Cheol Ung Choi, Hong Euy Lim, Jin Won Kim, Eung Ju Kim, Chang Gyu Park, Hong Seog Seo, Dong Joo Oh
January 03, 2012
Tissue coverage and neointimal hyperplasia of overlap vs. non-overlap segments in drug-eluting stents 9-13 months after implantation: in vivo-assessment with optical coherence...
Presentation TCT 2012

Tissue coverage and neointimal hyperplasia of overlap vs. non-overlap segments in drug-eluting stents 9-13 months after implantation: in vivo-assessment with optical coherence...

Presenter: Juan Luis Guti?rrez-Chico, Lorenz R?ber, Evelyn Regar, Takayuki Okamura, Carlo di Mario, Stephan Windecker, Gerrit-Anne van Es, Patrick W. Serruys
January 03, 2012
The Nine-Month Outcomes of a Polymer-Free Drug-Eluting Stent (YUKON) Compared with Different Polymer Based Drug-Eluting Stents in Real-World Coronary Artery Lesions.
Presentation TCT 2012

The Nine-Month Outcomes of a Polymer-Free Drug-Eluting Stent (YUKON) Compared with Different Polymer Based Drug-Eluting Stents in Real-World Coronary Artery Lesions.

Presenter: Ted S. Trajceski, Lulzim Brovina, Zivko Petrovski, Blerim Zuna, Borce Petrovski
January 03, 2012
The Impact of XIENCE V® Everolimus-Eluting Coronary Stents on Health Status in COURAGE-Like Patients.
Presentation TCT 2012

The Impact of XIENCE V® Everolimus-Eluting Coronary Stents on Health Status in COURAGE-Like Patients.

Presenter: David R. Rutledge, James B. Hermiller, Jin Wang, Mitchell W. Krucoff
January 03, 2012
Short-term effects of sirolimus eluting fully bioabsorbable polymeric coronary stents in a porcine model
Presentation TCT 2012

Short-term effects of sirolimus eluting fully bioabsorbable polymeric coronary stents in a porcine model

Presenter: Li Shen, Qibing Wang, Yizhe Wu, Jian Xie, Junbo Ge
January 03, 2012
Safety and Efficacy of the Xience Everolimus Eluting Stent Compared to First-Generation Drug-Eluting Stents in Contemporary Clinical Practice.
Presentation TCT 2012

Safety and Efficacy of the Xience Everolimus Eluting Stent Compared to First-Generation Drug-Eluting Stents in Contemporary Clinical Practice.

Presenter: Israel M. Barbash, Rebecca Torgusson, Itsik Ben-Dor, Gabriel Maluenda, Zhenyi Xue, William O. Suddath, Lowell F. Satler, Kenneth M. Kent, Augusto D. Pichard, Ron Waksman
January 03, 2012
Safety and Effectiveness of Everolimus-Eluting Stents in 5054 Patients from a Large, Prospective, Real World Study: Two-Year Clinical Outcomes from the XIENCE V® USA Study.
Presentation TCT 2012

Safety and Effectiveness of Everolimus-Eluting Stents in 5054 Patients from a Large, Prospective, Real World Study: Two-Year Clinical Outcomes from the XIENCE V® USA Study.

Presenter: Mitchell W. Krucoff, David R. Rutledge, Vivian W. Mao, Weiying Zhao, Alena V. Pechonkina, Jin Wang, Lalitha K. Jonnavithula, Krishnankutty Sudhir, James B. Hermiller
January 03, 2012
Response of Endothelial Progenitor Cells To Antiproliferative Drugs Currently Used in Drug Eluting Stents
Presentation TCT 2012

Response of Endothelial Progenitor Cells To Antiproliferative Drugs Currently Used in Drug Eluting Stents

Presenter: Hao Xu, Kytai T. Nguyen, Lance S. Terada, Eric Fuh, Joseph A. Garcia, Emmanouil S. Brilakis, Deepak L. Bhatt, Subhash Banerjee
January 03, 2012
Predictors Of Adverse Cardiac Events after PCI With GENOUS EPC-Coated Stents Compared To Drug Eluting Stents
Presentation TCT 2012

Predictors Of Adverse Cardiac Events after PCI With GENOUS EPC-Coated Stents Compared To Drug Eluting Stents

Presenter: Boris Rudenko, Anatoly Savchenko, Serdgey Tereshchenko, Olga Cherkavskaya
January 03, 2012
Pharmacokinetic Evaluation of Drug Eluting Stents in a Healthy and Atherosclerotic Rabbit Iliac Model
Presentation TCT 2012

Pharmacokinetic Evaluation of Drug Eluting Stents in a Healthy and Atherosclerotic Rabbit Iliac Model

Presenter: Alexander Sheehy, Saami K. Yazdani, Ed Berger, Rosy S. Donn, Tu D. Ngo, Stephen Pacetti, Syed Hossainy, Frank D. Kolodgie, Renu Virmani
January 03, 2012
Outcomes Following Unprotected Left Main Stenting with Everolimus-Eluting Stents: the Milan Experience.
Presentation TCT 2012

Outcomes Following Unprotected Left Main Stenting with Everolimus-Eluting Stents: the Milan Experience.

Presenter: Gill L. Buchanan, Alfonso Ielasi, Alaide Chieffo, Matteo Montorfano, Cosmo Godino, Azeem Latib, Mauro Carlino, Antonio Colombo
January 03, 2012
Outcomes After Revascularization with Everolimus- and Sirolimus Eluting Stents In Patients with Acute Coronary Syndromes. A Substudy of the SORT OUT IV Trial.
Presentation TCT 2012

Outcomes After Revascularization with Everolimus- and Sirolimus Eluting Stents In Patients with Acute Coronary Syndromes. A Substudy of the SORT OUT IV Trial.

Presenter: Lisbeth Antonsen, Per Thayssen, Henrik Steen Hansen, Michael Maeng, Hans-Henrik Tilsted, Evald Hoej Christiansen, Knud Noerregaard Hansen, Hans Erik Boetker, Jan Ravkilde, Lars Krusell, Morten Madsen, Henrik Toft Soerensen, Leif Thuesen, Jens Flensted Lassen, Lisette Okkels Jensen
January 03, 2012
No Difference In Long-term Major Adverse Cardiac Event Rates Between Paclitaxel-eluting and Sirolimus-eluting Stents.
Presentation TCT 2012

No Difference In Long-term Major Adverse Cardiac Event Rates Between Paclitaxel-eluting and Sirolimus-eluting Stents.

Presenter: James P. Howard, Zia Buckhoree, Dan A. Jones, Sean M. Gallagher, Krishnaraj S. Rathod, Ajay K. Jain, Charles Knight, Anthony Mathur, Andrew Wragg
January 03, 2012
Long-term Safety and Effectiveness of Drug Eluting Stents Compared to Bare Metal Stents in Non ST Elevation Myocardial Infarction: Findings from the Guthrie Health Off-Label...
Presentation TCT 2012

Long-term Safety and Effectiveness of Drug Eluting Stents Compared to Bare Metal Stents in Non ST Elevation Myocardial Infarction: Findings from the Guthrie Health Off-Label...

Presenter: Sudhakar Sattur, Pam Orshaw, Judy Boura, Kishore Harjai
January 03, 2012
Long-term outcome after percutaneous coronary intervention with titanium-nitride-oxide-coated stents versus paclitaxel-eluting stents in acute myocardial infarction: a...
Presentation TCT 2012

Long-term outcome after percutaneous coronary intervention with titanium-nitride-oxide-coated stents versus paclitaxel-eluting stents in acute myocardial infarction: a...

Presenter: Petri O. Tuomainen, Antti Ylitalo, Matti Niemel?, Mikko Pietil?, Jussi Sia, Kai Nyman, Juhani Airaksinen, Pasi P. Karjalainen
January 03, 2012
Lipoprotein(a) level and 2-year clinical outcomes in patients in Patients Undergoing Percutaneous Coronary Intervention with Drug-eluting Stents
Presentation TCT 2012

Lipoprotein(a) level and 2-year clinical outcomes in patients in Patients Undergoing Percutaneous Coronary Intervention with Drug-eluting Stents

Presenter: Sang-Ho Park, Seung Woon Rha, A-Ra Cho, Jae Yun Kim, Hyeok-Gyu Lee, Se-Whan Lee, Won-Yong Shin, Seung-Jin Lee, Dong-Kyu Jin, Byoung Geol Choi, Amro Elnagar, Sung Il Im, SunWon Kim, Jin Oh Na, Seong Woo Han, Cheol Ung Choi, Hong Euy Lim, Jin Won Kim, Eung Ju Kim, Chang Gyu Park, Hong Seog Seo, Dong Joo Oh
January 03, 2012
Left Main Bifurcation Stenting: Long Term Followup of Simultaneous Kissing Stents in 140 Consecutive, Unselected Patients
Presentation TCT 2012

Left Main Bifurcation Stenting: Long Term Followup of Simultaneous Kissing Stents in 140 Consecutive, Unselected Patients

Presenter: Julian Gunn, Anjan Siotia, Chris Malkin, Tushar Raina, Allison C. Morton
January 03, 2012
Incidence of Periprocedural Myocardial Infarction Following Stent Implantation: Comparison Between First and Second  Generation Drug-Eluting Stents
Presentation TCT 2012

Incidence of Periprocedural Myocardial Infarction Following Stent Implantation: Comparison Between First and Second Generation Drug-Eluting Stents

Presenter: Kenneth Tandjung, Mounir W. Basalus, Esther Muurman, Hans Louwerenburg, K. Gert van Houwelingen, Martin G. Stoel, Frits H. de Man, Hanneke Jansen, Jennifer Huisman, Gerard C. Linssen, Herman T. Droste, Mark B. Nienhuis, Clemens von Birgelen
January 03, 2012
Impact of Stent Platform of Paclitaxel-eluting Stents: Detailed Assessment of Neointimal Distribution by Optical Coherence Tomography
Presentation TCT 2012

Impact of Stent Platform of Paclitaxel-eluting Stents: Detailed Assessment of Neointimal Distribution by Optical Coherence Tomography

Presenter: Hiromasa Otake, Toshiro Shinke, Junya Shite, Masayuki Nakagawa, Ryoji Nagoshi, Tsuyoshi Osue, Ken-ichi Hirata
January 03, 2012
Impact of Renal Impairment on Clinical and Angiographic Outcomes After Percutaneous Coronary Intervention with Drug-Eluting Stents: a Pooled Analysis of SIRTAX, LEADERS, and...
Presentation TCT 2012

Impact of Renal Impairment on Clinical and Angiographic Outcomes After Percutaneous Coronary Intervention with Drug-Eluting Stents: a Pooled Analysis of SIRTAX, LEADERS, and...

Presenter: Giulio G. Stefanini, Bindu Kalesan, Lorenz Raber, Thomas Pilgrim, Yoshinobu Onuma, Sigmund Silber, Patrick W. Serruys, Bernhard Meier, Peter Juni, Stephan Windecker
January 03, 2012

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 36
  • Page 37
  • Page 38
  • Page 39
  • Page 40
  • Current page 41
  • Page 42
  • Page 43
  • Page 44
  • Next page ››
  • Last page Last »
Advertisement
Become a Member

Register for TCTMD ®

Membership Plans
Sign Up for Our Newsletter

Receive the the latest news, research, and presentations from major meetings right to your inbox.

TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of innovation in research and education that will help doctors save and improve the quality of their patients’ lives. For more information, visit http://www.crf.org.

Main Navigation

  • News
  • Conferences
  • Slides
  • Videos
  • Podcasts
  • Fellows Forum
  • CV Team Forum
  • CME

Specialty Menu Navigation

  • COVID-19

  • Clinical

  • Coronary

  • Structural

  • Endovascular

  • Heart Failure

  • Heart Rhythm

  • Imaging & Physiology

  • Policy & Practice

Footer

  • Advertising & Sponsorships
  • About TCTMD ®
  • FAQs
  • Editorial Policy
  • Contact Us
  • About CRF ®
Digital Health Awards Winner - Spring 2017 eHealthcare Leadership Awards - 2018 Winner HON Code Certified
Copyright © 2026. TCTMD ® All rights reserved.
  • Privacy Policy
  • Terms of Use
Created by Constructive
Sign In

New at TCTMD? Register today!

Forgot Password

Forgot Your Password?

Enter the email you used to register to reset your password.

Search TCTMD
cme
CME TITLE
Sign up for our newsletter

Sign up to receive the most important cardiovascular news, research, and major meeting presentations.

Address
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Main navigation

  • News
    • Conference News
    • Features
    • Opinion
  • Conferences
  • Slides
  • Specialties
    • COVID-19
    • Clinical
    • Coronary
    • Structural
    • Endovascular
    • Heart Failure
    • Heart Rhythm
    • Imaging & Physiology
    • Policy & Practice
  • Podcasts
    • Heart Sounds
    • Rox Heart Radio
    • TCTMD Talking Points
    • Taking It To Heart
    • Heart Valve Matters
    • Hearts & Minds
  • Videos
    • All Videos
    • Interviews
    • Topical Discussions
    • On Record
    • Live Cases
    • Partner Content
  • Fellows Forum
  • CV Team Forum
  • AI Exchange

Top User Menu

  • CME
  • Register
  • Login

Search TCTMD

Submit an Event
< >

Become a PREMIUM MEMBER or LOG IN to view exclusive content

This content is available for meeting attendees and/or Platinum Members

REGISTER for free or LOG IN to view this content

Now Playing